The regulatory T cells in anti-influenza antibody response post influenza vaccination

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 9, 2012, Pages 1243-1249

  Wang, Shih Min ^a,c   Tsai, Ming Hsun ^b   Lei, Huan Yao ^b,c   Wang, Jen Ren ^b,c   Liu, Ching Chuan ^a,c  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Antibody; Cytokine; Influenza; Regulatory T cell; Vaccine

Indexed keywords

GAMMA INTERFERON; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIBODY;

ADULT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CD25+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL FUNCTION; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MALE; NORMAL HUMAN; OUTCOME ASSESSMENT; POST EXPOSURE PROPHYLAXIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 TH2 BALANCE; VACCINATION;

ADULT; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKIN-5; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84866997757     PISSN: None     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.21117     Document Type: Article

References (34)

1. Wright PF, Neuman G, Kawaoka Y. Orthomyxoviruses. In: Knipe DM, Howley PM, Griffin DE, Martin MA, Ramb RA, Roizman B, et al, editors. Fields virology 5th ed. Philadelphia Lippincott-Raven; 2007, 1691-740.
2. McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 2002; 186:341-50; PMID:12134230; http://dx.doi.org/10.1086/341462.
3. de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, Nguyen BH, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005; 352:686-91; PMID:15716562; http://dx.doi.org/10.1056/ NEJMoa044307.
4. Trifonov V, Khiabanian H, Rabadan R. Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus. N Engl J Med 2009; 361:115-9; PMID:19474418; http://dx.doi.org/10.1056/NEJMp0904572.
5. Neuzil KM, Jackson LA, Nelson J, Klimov A, Cox N, Bridges CB, et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis 2006; 194:1032-9; PMID:16991077; http://dx.doi.org/10.1086/507309.
6. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 2008; 26(Suppl 4):D31-4; PMID:19230156; http://dx.doi.org/10.1016/j.vaccine.2008.07.078.
7. Ohmit SE, Victor JC, Rotthoff JR, Teich ER, Truscon RK, Baum LL, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 2006; 355:2513-22; PMID:17167134; http://dx.doi.org/10. 1056/NEJMoa061850.
8. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22:531-62; PMID:15032588; http://dx.doi.org/10.1146/annurev.immunol.21.120601. 141122.
9. Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat Immunol 2002; 3:756-63; PMID:12089509.
10. Ziegler SE, Morella KK, Anderson D, Kumaki N, Leonard WJ, Cosman D, et al. Reconstitution of a functional interleukin (IL)-7 receptor demonstrates that the IL-2 receptor gamma chain is required for IL-7 signal transduction. Eur J Immunol 1995; 25:399-404; PMID:7875201; http://dx.doi.org/10.1002/eji. 1830250214.
11. Chabalgoity JA, Baz A, Rial A, Grille S. The relevance of cytokines for development of protective immunity and rational design of vaccines. Cytokine Growth Factor Rev 2007; 18:195-207; PMID:17347024; http://dx.doi.org/10.1016/j. cytogfr.2007.01.016.
12. Yucesoy B, Johnson VJ, Fluharty K, Kashon ML, Slaven JE, Wilson NW, et al. Influence of cytokine gene variations on immunization to childhood vaccines. Vaccine 2009; 27:6991-7; PMID:19819209; http://dx.doi.org/10.1016/j.vaccine. 2009.09.076.
13. Wan YY, Flavell RA. 'Yin-Yang' functions of transforming growth factor-β and T regulatory cells in immune regulation. Immunol Rev 2007; 220:199-213; PMID:17979848; http://dx.doi.org/10.1111/j.1600-065X.2007.00565.x.
14. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 2003; 198:1875-86; PMID:14676299; http://dx.doi.org/10.1084/jem.20030152.
15. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006; 24:677-88; PMID:16782025; http://dx.doi.org/10.1016/j.immuni.2006.06.002.
16. Potter CW, Oxford JS. Determinants of immunity to influenza infection in man. Br Med Bull 1979; 35:69-75; PMID:367490.
17. Hirota Y, Kaji M, Ide S, Kajiwara J, Kataoka K, Goto S, et al. Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness. Vaccine 1997; 15:962-7; PMID:9261942; http://dx.doi.org/10.1016/S0264-410X(96)00302-7.
18. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al.; Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59(RR-8):1-62; PMID:20689501.
19. van't Land B, Schijf M, van Esch BCAM, van Bergenhenegouwen J, Bastiaans J, Schouten B, et al. Regulatory T-cells have a prominent role in the immune modulated vaccine response by specific oligosaccharides. Vaccine 2010; 28:5711-7; PMID:20600499; http://dx.doi.org/10.1016/j.vaccine.2010.06.046.
20. Cone RE, Bhowmick S. Cytokines and sympathy: the control of regulatory T cells. Int J Interferon Cytokine Mediator Res 2010; 2:41-7; http://dx.doi.org/ 10.2147/IJICMR.S6758.
21. Surls J, Nazarov-Stoica C, Kehl M, Casares S, Brumeanu T-D. Differential effect of CD4+Foxp3+ T-regulatory cells on the B and T helper cell responses to influenza virus vaccination. Vaccine 2010; 28:7319-30; PMID:20832492; http://dx.doi.org/10.1016/j.vaccine.2010.08.074.
22. - CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc Natl Acad Sci U S A 2005; 102:4091-6; PMID:15753306; http://dx.doi.org/10.1073/pnas.0408679102.
23. Wang J, Ioan-Facsinay A, van der Voort EIH, Huizinga TWJ, Toes REM. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 2007; 37:129-38; PMID:17154262; http://dx.doi.org/10.1002/eji. 200636435.
24. Sharma MD, Hou DY, Baban B, Koni PA, He Y, Chandler PR, et al. Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice. Immunity 2010; 33:942-54; PMID:21145762; http://dx.doi.org/10.1016/j.immuni.2010.11.022.
25. + regulatory T cells. Eur J Immunol 2010; 40:2528-38; PMID:20690182; http://dx.doi.org/10.1002/eji.201040531.
26. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003; 4:1191-8; PMID:14625547; http://dx.doi.org/10.1038/ni1009.
27. Huang J, Ma R, Wu CY. Immunization with SARSCoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses. Vaccine 2006; 24:4905-13; PMID:16621188; http://dx.doi.org/10.1016/j.vaccine.2006.03.058.
28. McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006; 176:6333-9; PMID:16670345.
29. McElhaney JE, Upshaw CM, Hooton JW, Lechelt KE, Meneilly GS. Responses to influenza vaccination in different T-cell subsets: a comparison of healthy young and older adults. Vaccine 1998; 16:1742-7; PMID:9778750; http://dx.doi.org/10.1016/S0264-410X(98)00133-9.
30. McElhaney JE, Hooton JW, Hooton N, Bleackley RC. Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults. Vaccine 2005; 23:3294-300; PMID:15837235; http://dx.doi.org/10.1016/j.vaccine.2005.01.080.
31. Sette AM, Moutaftsi M, Moyron-Quiroz J, McCausland MM, Davies DH, Johnston RJ, et al. Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities. Immunity 2008; 28:847-58; PMID:18549802; http://dx.doi.org/10.1016/j.immuni.2008.04.018.
32. Casares N, Rudilla F, Arribillaga L, Llopiz D, Riezu-Boj JI, Lozano T, et al. A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice. J Immunol 2010; 185:5150-9; PMID:20870946; http://dx.doi.org/10.4049/jimmunol.1001114.
33. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203:1693-700; PMID:16818676; http://dx.doi.org/10.1084/jem.20060468.
34. Gavin MA, Torgerson TR, Houston E, DeRoos P, Ho WY, Stray-Pedersen A, et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A 2006; 103:6659-64; PMID:16617117; http://dx.doi.org/10.1073/pnas.0509484103.